yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q36174265-23BACA2D-8258-4066-8A6E-E2516EEC7CDF
Q36174265-23BACA2D-8258-4066-8A6E-E2516EEC7CDF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36174265-23BACA2D-8258-4066-8A6E-E2516EEC7CDF
Risk assessment of mechanism-based inactivation in drug-drug interactions.
P2860
Q36174265-23BACA2D-8258-4066-8A6E-E2516EEC7CDF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36174265-23BACA2D-8258-4066-8A6E-E2516EEC7CDF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1945cf677f9f4d609956d898587cd23c06b12f99
P2860
Dose of midazolam should be reduced during diltiazem and verapamil treatments.